No Data
No Data
Earnings Preview: AXDX to Report Financial Results Post-market on November 07
Accelerate Diagnostics Scheduled Call to Review 2024 Third Quarter Results
Accelerate Diagnostics Stock Down Despite FDA Clearance for Arc System
Accelerate Diagnostics Announces FDA Clearance Of Its Accelerate Arc System, An Automated Platform Designed To Fight Against Sepsis And Antimicrobial Resistance
Express News | Accelerate Diagnostics Announces FDA Clearance of Its Accelerate ARC™ System
Accelerate Diagnostics (AXDX) Completes WAVE Pre-Clinical Trial
No Data
No Data